Teplizumab (Tzield)

On this page
What is teplizumab (Tzield)?
Teplizumab (brand name Tzield) is a medication that can delay the onset of type 1 diabetes in people at high risk of developing the condition.
How does teplizumab work?
In type 1 diabetes, the immune system mistakenly attacks insulin-producing cells in the pancreas called beta cells. This reduces insulin production over time, causing blood sugar levels to rise. Eventually, the patient must take supplemental insulin for life.
Teplizumab works by modifying immune cells called T cells, which slows the destruction of beta cells. This allows the pancreas to continue making insulin longer, delaying the need for insulin therapy. One study showed that teplizumab postponed the need for supplemental insulin by two years on average.
Who Is eligible for teplizumab?
The Food and Drug Administration (FDA) has approved teplizumab for patients age 8 and older who are at high risk of developing type 1 diabetes. To be considered high risk, you must meet the following criteria:
- Have at least two autoantibodies (antibodies that attack normal substances made by the body)
- Show elevated blood sugar levels, such as an A1C test result in the prediabetic range or an abnormal result on an oral glucose tolerance test
- Not yet require insulin therapy
These are the features of stage 2 diabetes. Stage 2 typically progresses to stage 3, when symptoms appear and supplemental insulin is needed.
Teplizumab is not approved for patients already diagnosed with type 1 diabetes.
What should I expect from teplizumab treatment?
First, you will be screened to determine whether you are eligible based on your autoantibodies and blood sugar levels. You'll have additional blood tests to check that your liver and kidneys are working normally and that you don't have any signs of an infectious disease.
If no safety concerns are found, you will receive teplizumab as a daily intravenous (IV) infusion for 14 consecutive days. These treatments take place in an outpatient infusion center and typically take two to three hours each.
Awards & recognition

Among the nation’s best in 13 specialties

One of the nation’s best for diabetes care & endocrinology

Rated high-performing hospital for diabetes care
Related treatments

Islet Transplant for Type I Diabetes
The procedure temporarily reverses diabetes, allowing many recipients to discard their blood glucose meters, pumps and syringes to live free from diabetes.
Pancreas Transplant
By restoring insulin production, a successful pancreas transplant can improve health issues caused by type 1 diabetes. Learn more.
Related services & conditions
Specialties
Conditions
- Type 1 Diabetes
- Pediatric Pre-Diabetes
Treatments
- Diabetes Therapy
UCSF Health medical specialists have reviewed this information. It is for educational purposes only and is not intended to replace the advice of your doctor or other health care provider. We encourage you to discuss any questions or concerns you may have with your provider.